Form 4: Integra LifeSciences Director Acquires Shares
Insider Transaction Report
Integra LifeSciences Holdings Corp. Director Keith Bradley acquired 17,700 restricted stock units and disposed of 88,254 shares.
Summary
- Director Keith Bradley acquired 17,700 restricted stock units (RSUs) on May 7, 2026, under the company's Equity Incentive Plan.
- These RSUs vest in full on the one-year anniversary of the grant date, May 7, 2026.
- On May 9, 2026, Bradley disposed of 88,254 shares of common stock at a price of $13.92 per share.
- Following these transactions, Bradley beneficially owns 88,254 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it details standard insider transactions including both the acquisition of equity incentives and the disposal of shares without further context.
Positives
- Director Keith Bradley received a grant of 17,700 restricted stock units, indicating continued incentive alignment with the company's performance.
- The RSUs vest in full after one year, suggesting a commitment period for the director.
Negatives
- Director Keith Bradley disposed of a significant number of shares (88,254) at a price of $13.92 per share.
Future Outlook
Restricted stock units granted on May 7, 2026, will vest in full on the one-year anniversary of the grant date, May 7, 2027.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The grant of RSUs suggests management's ongoing compensation structure, while the disposal of shares by a director warrants attention for potential insights into insider sentiment, though the specific reasons for the disposal are not provided in this filing.
Stakeholder Impact
- Shareholders: The disposal of shares by a director may be interpreted by the market, though the context of the transaction is not fully detailed in the filing.
Next Steps
- Vesting of 17,700 restricted stock units on May 7, 2027.
Key Dates
| Date | Description |
|---|---|
| 2003-01-01T00:00:00.000Z | Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan established (implied). |
| 2026-05-07T00:00:00.000Z | Earliest transaction date; Grant date for 17,700 restricted stock units. |
| 2026-05-09T00:00:00.000Z | Transaction date for the disposal of 88,254 shares of common stock. |
| 2026-05-11T00:00:00.000Z | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Form 4, SEC Filing, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Integra LifeSciences, IART, Director Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.